MAIA Biotechnology, Inc. MAIA
1.20
(0.05)
(4.00%)
as of 25 Sep
- Market cap
- $76.0M
- P/E
- 0.0×
Follow MAIA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
1.18 | 1.66 | 5.59 | 4.51 |
Net Debt/EBITDA |
1.16 | 2.01 | 4.95 | 3.32 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.39 | 1.93 | 0.83 | 0.85 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.10) | (0.22) | (0.12) | (0.11) | |
Cash per Share |
0.33 | 0.27 | 0.76 | 0.45 | |
Shareholders Equity per Share |
0.00 | 0.07 | 0.61 | 0.34 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.07 | 0.61 | 0.34 | |
Free Cash Flow |
(3.49) | (7.02) | (5.31) | (6.75) | |
Working Capital |
1.76 | 3.87 | 28.99 | 21.98 | |
Net Current Asset Value |
0.01 | 2.37 | 27.76 | 20.67 | |
| Other line items | |||||
Quick Ratio |
1.10 | 1.48 | 5.44 | 4.41 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.10) | (0.22) | (0.12) | (0.11) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
0.07 | — | — | — | |
Average Payables |
2.16 | 1.78 | 2.41 | 2.28 | |
Average Assets |
10.51 | 9.93 | 23.59 | 19.64 | |
Average Common Equity |
0.83 | 3.01 | 16.35 | 12.28 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates